摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-((6-amino-2-methylpyridin-3-yl)methyl)-1-((2-methylquinolin-6-yl)methyl)-1H-pyrazole-4-carboxamide | 1357954-51-8

中文名称
——
中文别名
——
英文名称
N-((6-amino-2-methylpyridin-3-yl)methyl)-1-((2-methylquinolin-6-yl)methyl)-1H-pyrazole-4-carboxamide
英文别名
N-[(6-amino-2-methylpyridin-3-yl)methyl]-1-[(2-methylquinolin-6-yl)methyl]pyrazole-4-carboxamide
N-((6-amino-2-methylpyridin-3-yl)methyl)-1-((2-methylquinolin-6-yl)methyl)-1H-pyrazole-4-carboxamide化学式
CAS
1357954-51-8
化学式
C22H22N6O
mdl
——
分子量
386.456
InChiKey
ATRKABUPNXFPKF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    29
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    98.7
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
    申请人:Brandl Trixi
    公开号:US09290485B2
    公开(公告)日:2016-03-22
    The invention relates to compound of the formula I in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    本发明涉及式I化合物,其中取代基如规范中所定义;以自由形式或盐形式存在;涉及其制备,用作药物以及包含它的药物。
  • N-((6-AMINO-PYRIDIN-3-YL)METHYL)-HETEROARYL-CARBOXAMIDES AS INHIBITORS OF PLASMA KALLIKREIN
    申请人:Novartis AG
    公开号:EP2601189A1
    公开(公告)日:2013-06-12
  • US9290485B2
    申请人:——
    公开号:US9290485B2
    公开(公告)日:2016-03-22
  • [EN] N-((6-AMINO-PYRIDIN-3-YL)METHYL)-HETEROARYL-CARBOXAMIDES AS INHIBITORS OF PLASMA KALLIKREIN<br/>[FR] N-((6-AMINO-PYRIDIN-3-YL)METHYL)-HETEROARYL-CARBOXAMIDES UTILISÉS COMME INHIBITEURS DE LA KALLICRÉINE PLASMATIQUE
    申请人:NOVARTIS AG
    公开号:WO2012017020A1
    公开(公告)日:2012-02-09
    The invention relates to compound of the formula (I) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
  • N-((6-AMINO-PYRIDIN-3-YL)METHYL)-HETEROARYL-CARBOXAMIDES
    申请人:BRANDL Trixi
    公开号:US20120035168A1
    公开(公告)日:2012-02-09
    The invention relates to compound of the formula I in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it.
    本发明涉及具有公式I的化合物,其中取代基如说明书中所定义;以自由形式或盐形式存在;及其制备方法,作为药品的使用,以及包含它的药品。
查看更多